Literature DB >> 40137

Binding of tricyclic antidepressants and perazine to human plasma. Methodology and findings in normals.

M Brinkschulte, U Breyer-Pfaff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 40137     DOI： 10.1007/bf00499712

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  22 in total

1.  The use of zonal ultracentrifugation in the investigation of the binding of delta9-tetrahydrocannabinol by plasma lipoproteins.

Authors:  H A Klausner; H G Wilcox; J V Dingell
Journal:  Drug Metab Dispos       Date:  1975 Jul-Aug       Impact factor: 3.922

Review 2.  Plasma level monitoring of antipsychotic drugs.

Authors:  T B Cooper
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

3.  Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors:  K M Piafsky; O Borgå
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

4.  Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

Authors:  M M Reidenberg; I Odar-Cederlöf; C von Bahr; O Borgå; F Sjöqvist
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

5.  Plasma binding of imipramine and clinical outcome.

Authors:  A H Glassman; M J Hurwic; J M Perel
Journal:  Am J Psychiatry       Date:  1973-12       Impact factor: 18.112

6.  Interactions of drugs with proteins. I. Binding of tricyclic thymoleptics to human and bovine plasma proteins.

Authors:  H J Weder; M H Bickel
Journal:  J Pharm Sci       Date:  1970-10       Impact factor: 3.534

7.  Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.

Authors:  M Ehrnebo; S Agurell; B Jalling; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

8.  Binding of reserpine to plasma albumin and lipoproteins.

Authors:  Z Chen; A Danon
Journal:  Biochem Pharmacol       Date:  1979       Impact factor: 5.858

9.  Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein.

Authors:  O G Nilsen; P Leren; I Aakesson; S Jacobsen
Journal:  Biochem Pharmacol       Date:  1978-03-15       Impact factor: 5.858

10.  Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate.

Authors:  O Borgå; K M Piafsky; O G Nilsen
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875
View more
  18 in total

1.  Serum protein binding of nonsteroidal antiinflammatory drugs: a comparative study.

Authors:  O Borgå; B Borgå
Journal:  J Pharmacokinet Biopharm       Date:  1997-02

Review 2.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 3.  Discrepancies between pharmacokinetic studies of amitriptyline.

Authors:  P Schulz; P Dick; T F Blaschke; L Hollister
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

4.  Determination of free fractions of tricyclic antidepressants.

Authors:  G Nyberg; E Mårtensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

5.  Absolute bioavailability of imipramine: influence of food.

Authors:  D R Abernethyl; M Divoll; D J Greenblatt; J S Harmatz; R I Shader
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Protein binding of enprofylline.

Authors:  K Tegnér; O Borgå; I Svensson
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Plasma protein binding of perazine and amitriptyline in psychiatric patients.

Authors:  M Brinkschulte; H J Gaertner; H W Schied; U Breyer-Pfaff
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  The pharmacokinetics of nortriptyline in patients with chronic renal failure.

Authors:  S Dawlilng; K Lynn; R Rosser; R Braithwaite
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

9.  Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance.

Authors:  G Schaber; I Stevens; H J Gaertner; K Dietz; U Breyer-Pfaff
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

10.  Pethidine binding in plasma: effects of methodological variables.

Authors:  C La Rosa; L E Mather; D J Morgan
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.